At a glance

ViiV Healthcare – an independent company 100% focused on the needs of people living with HIV
Our aim is to take a deeper and broader interest in HIV/AIDS than any company has done before
ViiV Healthcare was established in November 2009, combining the power and expertise in the management of HIV from both GSK and Pfizer. Shionogi joined ViiV Healthcare in 2012.
Our portfolio is built on 10 available medicines that generate annual sales of more than £1.5 billion, providing us with financial stability, investment capital and enabling us to take a sustainable, long-term view
We have an industry-leading pipeline including four compounds in Phase II or Phase III development
We are committed to develop further fixed dose combinations of antiretroviral drugs that will meet the needs of specific groups of people living with HIV
We support fresh approaches to improve access to HIV treatments
ViiV Healthcare supports sustainable community projects making a difference at grassroots level in over 46 countries